Stryker (SYK) to Release Quarterly Earnings on Thursday
Stryker (NYSE:SYK) is scheduled to be announcing its Q214 earnings results on Thursday, July 17th. Analysts expect the company to announce earnings of $1.08 per share and revenue of $2.35 billion for the quarter. Stryker has set its FY14 guidance at $4.75-4.90 EPS.Investors that wish to register for the company’s conference call can do so using this link.
Stryker (NYSE:SYK) last announced its earnings results on Wednesday, April 23rd. The company reported $1.06 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.09 by $0.03. The company had revenue of $2.31 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the company posted $1.03 earnings per share. Stryker’s revenue was up 5.3% compared to the same quarter last year. On average, analysts expect Stryker to post $4.80 EPS for the current fiscal year and $5.28 EPS for the next fiscal year.
Stryker (NYSE:SYK) opened at 82.74 on Wednesday. Stryker has a 1-year low of $66.44 and a 1-year high of $86.93. The stock has a 50-day moving average of $84.51 and a 200-day moving average of $80.81. The company has a market cap of $31.366 billion and a price-to-earnings ratio of 41.33.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Thursday, July 10th. They now have a $88.00 price target on the stock. On a related note, analysts at Cantor Fitzgerald raised their price target on shares of Stryker from $78.00 to $84.00 in a research note on Tuesday, July 1st. Finally, analysts at Argus upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Wednesday, June 11th. They now have a $102.00 price target on the stock. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Stryker currently has a consensus rating of “Buy” and a consensus price target of $83.22.
In other Stryker news, Director Ronda E. Stryker sold 14,000 shares of the stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $82.77, for a total transaction of $1,158,780.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Stryker Corporation (NYSE:SYK) is a medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.